Blocking the CD47-SIRPa axis in non-alcoholic steatohepatitis enhances necroptotic hepatocyte uptake and improves hepatic fibrosis

被引：0
|
作者：
Shi, Hongxue [1 ]
Wang, Xiaobo [1 ]
Gerlach, Brennan [1 ]
Yurdagul, Arif [2 ]
Cai, Bishuang [3 ]
Zeldin, Sharon [1 ]
Valenti, Luca [4 ]
Tabas, Ira [1 ]
机构：
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
[2] LSU Hlth Shreveport, Mol & Cellular Physiol, Shreveport, LA USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Univ Milan, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-2653
引用
收藏
页码：S607 / S607
页数：1
相关论文
共 50 条
  • [1] BLOCKING THE CD47-SIRP. AXIS IN NONALCOHOLIC STEATOHEPATITIS ENHANCES NECROPTOTIC HEPATOCYTE UPTAKE AND IMPROVES HEPATIC FIBROSIS
    Shi, Hongxue
    Wang, Xiaobo
    Moore, Mary P.
    Yurdagul, Arif
    Cai, Bishuang
    Valenti, Luca
    Tabas, Ira
    HEPATOLOGY, 2022, 76 : S664 - S665
  • [2] Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis
    Biedermann, Alexander
    Mangelberger-Eberl, Doris
    Mougiakakos, Dimitrios
    Buettner-Herold, Maike
    Flamann, Cindy
    Kellner, Christian
    Altmeyer, Sarah
    Bittenbring, Joerg
    Augsberger, Christian
    Patra-Kneuer, Maria
    Landgraf, Karin
    Ilieva-Babinsky, Kristina
    Haskamp, Stefan
    Beier, Fabian
    Voelkl, Simon
    Pallasch, Christian
    Jacobs, Benedikt
    Steidl, Stefan
    Heitmueller, Christina
    Mackensen, Andreas
    Bruns, Heiko
    BLOOD, 2022, 140 : 9292 - 9293
  • [3] Targeting CD47-SIRPa axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
    Zhao, Pengcheng
    Xie, Longyan
    Yu, Lei
    Wang, Ping
    GENES & DISEASES, 2024, 11 (01) : 205 - 217
  • [4] SILYMARIN IMPROVES FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS
    Chan, W. K.
    Mustapha, N. R. N.
    Mahadeva, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S225 - S226
  • [5] Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
    Rombouts, Krista
    Marra, Fabio
    DIGESTIVE DISEASES, 2010, 28 (01) : 229 - 235
  • [6] CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis
    Song, Yiran
    Li, Chenyang
    Luo, Yuxin
    Guo, Jinbo
    Kang, Yaxing
    Yin, Fengrong
    Ye, Lihong
    Sun, Donglei
    Yu, Jun
    Zhang, Xiaolan
    LIVER INTERNATIONAL, 2023, 43 (02) : 357 - 369
  • [7] CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
    Shi, Hongxue
    Wang, Xiaobo
    Li, Fang
    Gerlach, Brennan D.
    Yurdagul, Arif, Jr.
    Moore, Mary P.
    Zeldin, Sharon
    Zhang, Hanrui
    Cai, Bishuang
    Zheng, Ze
    Valenti, Luca
    Tabas, Ira
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (672)
  • [8] Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
    Overi, Diletta
    Carpino, Guido
    Franchitto, Antonio
    Onori, Paolo
    Gaudio, Eugenio
    CELLS, 2020, 9 (03)
  • [9] BLOCKING "DON'T-EAT-ME" SIGNAL OF CD47-SIRPa BY ANTI-SIRPa ANTIBODY ENHANCES ANTI-TUMOR EFFICACY OF TRASTUZUMAB DERUXTECAN
    Sue, Mayumi
    Tsubaki, Takuya
    Ishimoto, Yoko
    Hayashi, Shinko
    Ishida, Saori
    Isumi, Yoshitaka
    Ishiguro, Jun
    Kawaida, Reimi
    Ohtsuka, Toshiaki
    Wada, Teiji
    Agatsuma, Toshinori
    Kawasaki, Norihito
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A844 - A844
  • [10] MODULATION OF HEPATIC FIBROSIS AND LIPID CONTENT BY CASPASE IN NON-ALCOHOLIC STEATOHEPATITIS
    Hatting, M.
    Cubero, F. J.
    Zhao, G.
    Schumacher, F.
    Sellge, G.
    Liedtke, C.
    Gassler, N.
    Trautwein, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S491 - S491
12345